AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims

Posted on:
Key Points

Sept 20 (Reuters) - AstraZeneca Pharmaceuticals LP (AZN.L) has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuses and stock options because she worked from home full-time...

Elmarie Bodes, who was AstraZeneca's senior director of business transformation until January, said in the lawsuit filed in South Carolina state court on Tuesday that she was owed a $124,000 performance bonus and $65,000 in stock options...

Instead, AstraZeneca earlier this year cut her payout in half and refused to grant any stock options because she did not come into the office at least three days per week, according to the lawsuit...

The lawsuit claims AstraZeneca gave no prior notice that it would condition bonuses on whether employees reported to the office...

The lawsuit is the latest to stem from the explosion of remote work that began during the COVID-19 pandemic, though most of the litigation involves claims that companies refused to cover expenses related to working from home or that workers with disabilities were unable to return to the office...